Dutasteride
Dutasteride has been studied in 6 papers since 2016: 5 observational studies in people, 1 review; 2 in the past year. It is an approved medicine. The newest paper, Mar 31, 2026: “Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study”.
See all 11 papers on dutasteride
At a glance
The findings reach people, from one lab or study. 4 independent labs in 5 countries; 59 trials, 1 about aging, 24 with no results posted.
“Men taking finasteride or dutasteride were at increased risk of all-cause dementia”
None of its findings points the other way.
- 4 independent labs in 5 countries
- 59 trials, 1 about aging, 24 with no results posted
- Funders: Forskningsrådet för hälsa, arbetsliv och välfärd and others
- 3 of 8 findings with company ties
- Humans5
What did studies of dutasteride find?
5Studies of dutasteride measured 5 outcomes, among them type 2 diabetes, suicide and stroke.
Type 2 diabetes
no changein humans1HR 0.97
1 study
Type 2 diabetes
no changein humans1HR 0.97
Dutasteride was not clearly linked with type 2 diabetes in humans (benign prostatic hyperplasia) (HR 0.97, 95% CI 0.92-1.02).
“that for dutasteride was 0.97 (95% CI, 0.92-1.02), when compared with tamsulosin users”
Humansbenign prostatic hyperplasiaat least 90 days
Yonsei medical journal
Suicide
no changein humans1HR 0.98
1 study
Suicide
no changein humans1HR 0.98
Dutasteride was not clearly linked with suicide in humans (HR 0.98, 95% CI 0.62-1.54).
“In contrast, 5-ARIs were not associated with suicide (finasteride: HR, 1.22 [95% CI, 0.99-1.49]; dutasteride: HR, 0.98 [95% CI, 0.62-1.54]).”
Humansmales
Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
JAMA network open
Stroke
no changein humans1HR 1.03
1 study
Stroke
no changein humans1HR 1.03
Dutasteride was not clearly linked with stroke in humans (relative to finasteride) (HR 1.03, 95% CI 0.88-1.20).
“Similarly, we found no difference in the risk of acute myocardial infarction (HR 0.94, 95% CI 0.82-1.08) or stroke (HR 1.03, 95% CI 0.88-1.20).”
Humansrelative to finasteridemales
The Cardiovascular Safety of Dutasteride
The Journal of urology
Acute myocardial infarction
no changein humans1HR 0.94
1 study
Acute myocardial infarction
no changein humans1HR 0.94
Dutasteride was not clearly linked with acute myocardial infarction in humans (relative to finasteride) (HR 0.94, 95% CI 0.82-1.08).
“Similarly, we found no difference in the risk of acute myocardial infarction (HR 0.94, 95% CI 0.82-1.08) or stroke (HR 1.03, 95% CI 0.88-1.20).”
Humansrelative to finasteridemales
The Cardiovascular Safety of Dutasteride
The Journal of urology
Hospitalization for heart failure
no changein humans1HR 0.98
1 study
Hospitalization for heart failure
no changein humans1HR 0.98
Dutasteride was not clearly linked with hospitalization for heart failure in humans (relative to finasteride) (adjusted HR 0.98, 95% CI 0.88-1.08).
“we found no difference in the risk of heart failure among patients receiving dutasteride relative to those receiving finasteride”
Humansrelative to finasteridemales
The Cardiovascular Safety of Dutasteride
The Journal of urology
What is dutasteride linked with?
3Studies link dutasteride with 3 measures: age-related macular degeneration, depression and all-cause dementia.
Age-related macular degeneration
upin humans1HR 1.13
1 study
Age-related macular degeneration
upin humans1HR 1.13
Dutasteride is linked with a higher risk of age-related macular degeneration in humans (benign prostate hyperplasia (BPH) patients in subgroup analysis) (HR: 1.13; 95% CI: 1.02-1.25).
“increased risk of incident age-related macular degeneration was observed in patients receiving dutasteride [HR: 1.13; 95% CI: 1.02-1.25]”
Humansbenign prostate hyperplasia (BPH) patients in subgroup analysismean follow-up of 3.7 yearsmales
Age and ageing
Depression
upin humans1HR 1.68
1 study
Depression
upin humans1HR 1.68
Dutasteride is linked with a higher risk of depression in humans (HR 1.68, 95% CI 1.43-1.96; constant risk over time).
“Both finasteride and dutasteride were similarly associated with depression with a constant risk over time”
Humansmales
Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
JAMA network open
All-cause dementia
upin humans1HR 1.1
1 study
All-cause dementia
upin humans1HR 1.1
Dutasteride is linked with a higher risk of all-cause dementia in humans (HR 1.10, 95% CI 1.01-1.20).
“Men taking finasteride or dutasteride were at increased risk of all-cause dementia”
Humansmales
Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
JAMA network open
Has dutasteride been tested in people?
1 of 59 about agingYes: 5 observational studies in people have been published, and 59 trials are registered.
About aging
Phase 1Completed
Approved
Nov 20, 2001
Every condition in trials
Phase 4Results posted24 trials
Prostatic neoplasm
Phase 4Results posted17 trials
Phase 4Results posted2 trials
Phase 3Results posted2 trials
Phase 3Terminated1 trial
Physiological sexual dysfunction
Phase 3Status unknown1 trial
All 17Fewer
Readouts due
- Apr 30, 2027
Perioperative Dutasteride for Hemorrhage Control in Bipolar TURP Under Anticoagulation.
Phase 4Not yet recruiting
Stopped
NCT00421421TerminatedProstatic hyperplasia
Incomplete information
NCT01673490TerminatedProstatic hyperplasia
The sole investigative site refused to accept the amended protocol and declined to continue the study. There was no safety signal nor any other reason.
NCT00431626TerminatedHyperplasia
Low enrollment
Trial sponsors
Company18 trialsPhase 415,660 people
Company1 trialPhase 3117 people
Company1 trialPhase 252 people
Company2 trialsPhase 1101 people
Company1 trialPhase 128 people
Company1 trialPhase 17 people
University of Connecticut Health Center
2 trialsPhase 4236 people
Turun Yliopistollinen Keskussairaala
1 trialPhase 4100 people